BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

671 related articles for article (PubMed ID: 29477956)

  • 1. An (un)desirable trade of harms? How elite athletes might react to medically supervised 'doping' and their considerations of side-effects in this situation.
    Overbye M
    Int J Drug Policy; 2018 May; 55():14-30. PubMed ID: 29477956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Australian athletes' knowledge of the WADA Prohibited Substances List and performance enhancing substances.
    Orr R; Grassmayr M; Macniven R; Grunseit A; Halaki M; Bauman A
    Int J Drug Policy; 2018 Jun; 56():40-45. PubMed ID: 29550541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doping in sport: a review of elite athletes' attitudes, beliefs, and knowledge.
    Morente-Sánchez J; Zabala M
    Sports Med; 2013 Jun; 43(6):395-411. PubMed ID: 23532595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clean Olympians? Doping and anti-doping: the views of talented young British athletes.
    Bloodworth A; McNamee M
    Int J Drug Policy; 2010 Jul; 21(4):276-82. PubMed ID: 20056401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Between medical treatment and performance enhancement: an investigation of how elite athletes experience Therapeutic Use Exemptions.
    Overbye M; Wagner U
    Int J Drug Policy; 2013 Nov; 24(6):579-88. PubMed ID: 23582632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of the COVID-19 pandemic on the use of the performance-enhancing drugs.
    Negro F; Di Trana A; Marinelli S
    Acta Biomed; 2022 Jan; 92(6):e2021401. PubMed ID: 35075058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there a danger for myopia in anti-doping education? Comparative analysis of substance use and misuse in Olympic racket sports calls for a broader approach.
    Kondric M; Sekulic D; Petroczi A; Ostojic L; Rodek J; Ostojic Z
    Subst Abuse Treat Prev Policy; 2011 Oct; 6():27. PubMed ID: 21988896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-reported attitudes of elite athletes towards doping: differences between type of sport.
    Alaranta A; Alaranta H; Holmila J; Palmu P; Pietilä K; Helenius I
    Int J Sports Med; 2006 Oct; 27(10):842-6. PubMed ID: 16586338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National doping prevention guidelines: Intent, efficacy and lessons learned - A 4-year evaluation.
    Wippert PM; Fließer M
    Subst Abuse Treat Prev Policy; 2016 Oct; 11(1):35. PubMed ID: 27724975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should performance-enhancing drugs in sport be legalized under medical supervision?
    Wiesing U
    Sports Med; 2011 Feb; 41(2):167-76. PubMed ID: 21244107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting elite Scottish athletes' attitudes towards doping: examining the contribution of achievement goals and motivational climate.
    Allen J; Taylor J; Dimeo P; Dixon S; Robinson L
    J Sports Sci; 2015; 33(9):899-906. PubMed ID: 25537139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Korean national athletes' knowledge, practices, and attitudes of doping: a cross-sectional study.
    Kim T; Kim YH
    Subst Abuse Treat Prev Policy; 2017 Feb; 12(1):7. PubMed ID: 28196542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doping knowledge, attitudes, and practices of Ugandan athletes': a cross-sectional study.
    Muwonge H; Zavuga R; Kabenge PA
    Subst Abuse Treat Prev Policy; 2015 Sep; 10():37. PubMed ID: 26395767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sports physicians and the doping crisis in elite sport.
    Hoberman J
    Clin J Sport Med; 2002 Jul; 12(4):203-8. PubMed ID: 12131053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, knowledge and attitude of prohibited substances use (doping) among Saudi sport players.
    Al Ghobain M; Konbaz MS; Almassad A; Alsultan A; Al Shubaili M; AlShabanh O
    Subst Abuse Treat Prev Policy; 2016 Apr; 11():14. PubMed ID: 27083557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treating the elite athlete: anti-doping information for the health professional.
    Tandon S; Bowers LD; Fedoruk MN
    Mo Med; 2015; 112(2):122-8. PubMed ID: 25958657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychological and social correlates of doping attitudes among Italian athletes.
    Zucchetti G; Candela F; Villosio C
    Int J Drug Policy; 2015 Feb; 26(2):162-8. PubMed ID: 25168080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Medication, athletes and doping regulations].
    Hartgens F
    Ned Tijdschr Geneeskd; 2008 Aug; 152(33):1844-8. PubMed ID: 18783164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doping in sport: effects, harm and misconceptions.
    Birzniece V
    Intern Med J; 2015 Mar; 45(3):239-48. PubMed ID: 25369881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of doping use in elite sports: a review of numbers and methods.
    de Hon O; Kuipers H; van Bottenburg M
    Sports Med; 2015 Jan; 45(1):57-69. PubMed ID: 25169441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.